CLENZIDERM PORE THERAPYACNE TREATMENT (OMP, INC.)
Welcome to the PulseAid listing for the CLENZIDERM PORE THERAPY drug offered from OMP, INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | OMP, INC. |
NON-PROPRIETARY NAME: | SALICYLIC ACID |
SUBSTANCE NAME: | SALICYLIC ACID |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2007-02-01 |
END MARKETING DATE: | 0000-00-00 |
CLENZIDERM PORE THERAPY ACNE TREATMENT HUMAN OTC DRUG Details:
Item Description | CLENZIDERM PORE THERAPY ACNE TREATMENT from OMP, INC. |
LABELER NAME: | OMP, INC. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2007-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62032-110_1d93c707-3b66-4904-bc9c-deda90d26ab8 |
PRODUCT NDC: | 62032-110 |
APPLICATION NUMBER: | part333D |